The relevant investigative protocol and/or patient note may be attached to your patient's printed or electronic result.

The range of investigative protocols cover conditions associated with:
Clinical Conditions
Abbreviation IP Title
Female - Infertility Investigation of infertility in females
Female - menstrual hormones (comb) Hormonal changes during menstrual cycle - combined
Female - menstrual hormones (ea) Hormonal changes during menstrual cycle by each hormone
Oligomenorrhoea Evaluation of irregular menstrual periods
Hypercholesterolaemia Investigation of familial hypercholesterolaemia
Hyperprolactinaemia Causes of hyperprolactinaemia (prolactin > 700 mIU/L)
Polyuria Evaluation of polyuria (urine volume > 3L/24hrs)
Coagulation Tests
Abbreviation IP Title
Platelet Platelet function analysis
Thrombosis Risk factors for venous thromboembolism
vWF1 von Willebrand disease
Endocrine Tests
Abbreviation IP Title
TSH High Evaluation of high serum TSH (> 4.0 mU/L)
TSH Low Evaluation of low serum TSH (< 0.2 mU/L)
General Biochemistry
Abbreviation IP Title
Bicarbonate - High Causes of high plasma HCO3
Bicarbonate - Low Causes of low plasma HCO3 (bicarbonate < 18)
CK Raised - Evaluation Causes of an elevated CK (M > 200 F > 140)
Hypercalcaemia Causes of hypercalcaemia (calcium > 2.6)
Hypercalcaemia - Evaluation Evaluation of hypercalcaemia
Hypocalcaemia - Evaluation Evaluation of hypocalcaemia (calcium < 2.2)
Hyperglobulinaemia - Evaluation Evaluation of hyperglobulinaemia (globulins > 44)
Hyperkalaemia Causes of hyperkalaemia (potassium > 5.0)
Hyperkalaemia - Evaluation Evaluation of hyperkalaemia (potassium > 5.0)
Hypokalaemia Causes of hypokalaemia (potassium < 3.0)
Hypokalaemia - Evaluation Evaluation of hypokalaemia (potassium < 3.0)
Hypomagnesaemia Causes of hypomagnesaemia (magnesium < 0.7mmol/L)
Hypernatraemia Causes of hypernatraemia
Hyponatraemia Causes of hyponatraemia (sodium < 130)
Hyperphosphataemia Causes of hyperphosphataemia (phosphate > 1.8)
Hypophosphataemia Causes of hypophosphataemia (mild 0.5~0.65 mmol/L; severe < 0.4 mmol/L)
Hyperuricaemia - Evaluation Evaluation of hyperuricaemia (M > 0.45 F > 0.40)
Immunology
Abbreviation IP Title
Coeliac Coeliac disease investigation
IgA Deficiency Evaluation of selective IgA deficiency
Plasma Cell Dyscrasia Evaluation of plasma cell dyscrasias
IgM Plasma Cell Dyscrasia Evaluation of IgM plasma cell dyscrasias
Liver Function Tests
Abbreviation IP Title
ALP Elevation Causes of an Isolated serum Alkaline Phosphatase (ALP) elevation (ALP > 180 IU/L)
ALP Elevation - Evaluation Evaluation of ALP elevation (ALP > 180 IU/L)
ALP Elevation Isolated - Evaluation Evaluation of an isolated serum ALP elevation - query growth related (age < 19 yrs)
ALP High - growth related Serum ALP elevation - query growth related (age < 19 yrs). See flowchart
ALP - High < 5 yo Marked serum ALP elevation (ALP > 700 IU/L age < 5 yrs)
Aminotransferase - evaluation Evaluation of a moderate elevation of aminotransferase levels (AST & ALT)
Hepatocellular pathology Predominant hepatocellular pathology (ALT or AST > 150 U/L ALP < 200 U/L)
Atypical LFT Evaluation of a LFT pattern not typical of liver disease (elevated LD, AST > ALT)
Hyperbilirubinaemia - causes Causes of an isolated hyperbilirubinaemia (bilirubin > 25 mmol/L)
Hyperbilirubinaemia - evaluation Evaluation of an isolated hyperbilirubinaemia (bilirubin > 30 mmol/L)
Jaundice - evaluation Evaluation of jaundice (ALT < 400 U/L ALP > 350 U/L)
Jaundice - evaluation 2 Evaluation of jaundice (ALT > 300 U/L ALP < 350 U/L)
Cholestasis - evaluation Evaluation of localised cholestasis (ALP > 180 U/L ALT < 150 U/L GGT > 100 U/L bilirubin < 50 umol/L)
Cholestatic Disease Evaluation of mixed hepatocellular and cholestatic disease (ALP > 180 U/L GGT > 65 U/L ALT or AST > 150 U/L)
Microbiology & Patient Notes
Abbreviation IP Title
Haematuria - causes Causes of isolated microscopic haematuria
Barmah Forest virus Symptoms, incubation, treatment and prevention of Barmah Forest virus
Blastocystosis Symptoms, infection period, diagnosis, treatment and prevention of blastocystosis
Cryptosporidiosis Symptoms, infection period, spread of infection and treatment of cryptosporidiosis
Giardiasis Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of giardiasis
Listeriosis Symptoms, causes, infection period, diagnosis, treatment and prevention of listeriosis
Parvovirus Causes, infection period, spread of infection, diagnosis, treatment and prevention of parvovirus
Ross River virus Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of Ross River virus
Serology
Abbreviation IP Title
Hep A & ALT Serological events in acute (self-limiting) Hepatitis A infection relative to Alanine Aminotransferase (ALT) peak
Hep B & ALT Serological events in acute (self-limiting) Hepatitis B infection relative to ALT peak
Hep B Hepatitis B immune status
Pertussis Treatment of Bordetella pertussis
Warfarin Management
Abbreviation IP Title
INR Ranges Range of International Normalised Ratio (INR) recommended for specific applications of warfarin therapy
INR - management Guidelines to the management of an elevated INR, with or without bleeding
Warfarin - Risk Factors Risk factors for bleeding complications of warfarin therapy
Cytology
Abbreviation IP Title
Abnormal Pap Management of Abnormal Pap Smears